NCT00812838 - H-22411: BOTOX® for Peyronie's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 7, 2009

Primary Completion Date

February 15, 2017

Study Completion Date

January 15, 2019

Conditions

Peyronie's Disease

Interventions

DRUG

100 units of Botulinum Toxin Type A

Approximately 20 to 30 injections of 100 units of BOTOX® given with a 20 gage needle directly into the penile plaque

OTHER

Preservative free normal saline

Approximately 20 to 30 injections of 10cc of preservative free normal saline given with a 20 gage needle directly into the penile plaque

DRUG

100 units Botulinum Toxin A

Approximately 20 to 30 injections of 100 units of BOTOX® given with a 20 gage needle directly into the penile plaque

Trial Locations (1)

Baylor College of Medicine, Houston